Document is current
Any future updates will be listed below
-
Authors
Menzies-Gow, Andrew
Colice, Gene
Griffiths, Janet M.
Almqvist, Gun
Ponnarambil, Sandhia
Kaur, Primal
Ruberto, Gennaro
Bowen, Karin
Hellqvist, Åsa
Mo, May
Garcia Gil, Esther
-
Funding
Funding for this research was provided by:
AstraZeneca
Amgen, Inc
- License Information
-
More Information
Article History
Received: 5 May 2020
Accepted: 1 October 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all patients or their guardians before enrolment into the study. The study was conducted in accordance with the principles established in the Declaration of Helsinki and the International Council for Harmonisation guidelines for good clinical practice.
: Not applicable.
: AMG has: attended advisory boards for AstraZeneca, GlaxoSmithKline, Novartis, Sanofi and Teva; received speaker fees from AstraZeneca, Novartis, Roche and Teva; participated in research with AstraZeneca, for which his institution has been remunerated; attended international conferences with Teva; and consultancy agreements with AstraZeneca, Sanofi and Vectura. GC, JMG, GA, SP, GR, KB, ÅH and EGG are employees of AstraZeneca. PK and MM are employees of Amgen Inc.
